Mumbai, Jul 22 (UNI) English Crown Court has quashed the case filed by UK Serious Fraud Office (SFO) against Ranbaxy's subsidiary-Ranbaxy UK.
The Court also declined an application by SFO to appeal to the English Court of Appeal.
Welcoming the decision, Ranbaxy, which is emberoiled with US Food&Drug Administration (FDA) over adulteration of its drugs, issued a release stating, ''Ranbaxy is a responsible company committed to provide high quality generic medicines at affordable prices to its customers and patients throughout the world.'' The SFO however retains a right to appeal to the Court of Appeal directly, stated the release today.
UNI ZC GR NP1305